Spyre Therapeutics, Inc. (SYRE)

43.72 +0.51 (+1.18%) USD  |  NASDAQ  |  Feb 23, 12:50
More

Spyre Therapeutics Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
PTC Therapeutics, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade